ATHN 7: Hemophilia Natural History Study
Public ClinicalTrials.gov record NCT03619863. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Hemophilia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a real-world study of the safety of the treatments used for people with hemophilia. The study will follow people with hemophilia A or B from across the country for about 4 years as they receive treatment. The hemophilia treatment center (HTC) physician and participant will decide on the FDA-approved treatment to be used which may include non-factor products, bypassing agents, or clotting factor replacement products. The goal of this research is to study the use of hemophilia treatment products and their outcomes.
Study identification
- NCT ID
- NCT03619863
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 395 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 24, 2018 (Actual)
- Primary completion
- May 31, 2023 (Actual)
- Completion
- Mar 31, 2024 (Actual)
- Last update posted
- Feb 12, 2025
2018 – 2024
United States locations
- U.S. sites
- 29
- U.S. states
- 22
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital | Phoenix | Arizona | 85016 | — |
| Orthopaedic Institute for Children HTC | Los Angeles | California | 90007 | — |
| Orthopedic Institute for Children Hemophilia Program | Los Angeles | California | 90007 | — |
| Rady Children's Hospital San Diego | San Diego | California | 92123 | — |
| Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| University of Florida Hemophilia Treatment Center | Gainesville | Florida | 32610 | — |
| Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta | Atlanta | Georgia | 30308 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Indiana Hemophilia and Thrombosis Center (IHTC) | Indianapolis | Indiana | 46260 | — |
| Louisiana Center for Bleeding and Clotting Disorders, Tulane University | New Orleans | Louisiana | 70112 | — |
| Louisiana Center for Bleeding and Clotting Disorders | New Orleans | Louisiana | 70112 | — |
| Maine Hemophilia and Thrombosis Center | Scarborough | Maine | 04074 | — |
| Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center | Boston | Massachusetts | 02114 | — |
| Michigan State University Center for Bleeding and Clotting Disorders | East Lansing | Michigan | 48823 | — |
| Children's Mercy Hospital - Kansas City | Kansas City | Missouri | 64108 | — |
| The John Bouhasin Center for Children with Bleeding Disorders | St Louis | Missouri | 63104 | — |
| Hemostasis and Thrombosis Center of Nevada | Las Vegas | Nevada | 89178 | — |
| Hemostasis and Thrombosis Center of Nevada | Reno | Nevada | 89509 | — |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07122 | — |
| Weill Cornell Medicine | New York | New York | 10065 | — |
| Wake Forest University Health Science | Winston-Salem | North Carolina | 27157 | — |
| Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital | Toledo | Ohio | 43606 | — |
| The Hemophilia Center at Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Children's Hospital of Philadelphia (CHOP) | Philadelphia | Pennsylvania | 19104 | — |
| Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| St Jude Children's Research Hospital | Memphis | Tennessee | 38105 | — |
| The Center for Cancer and Blood Disorders, Children's Medical Center of Dallas | Dallas | Texas | 75235 | — |
| Gulf States Hemophilia and Thrombosis Center | Houston | Texas | 77030 | — |
| Comprehensive Center for Bleeding Disorders | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03619863, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03619863 live on ClinicalTrials.gov.